EMA recommendation on hydroxyethyl starch solutions obscured controversy
Abstract
As the EMA’s recommendation to suspend HES solutions from the market heads to the European Commission for a final decision, scientists who were asked to provide independent advice say that they were completely ignoredCitation
Doshi, P. (2018). EMA recommendation on hydroxyethyl starch solutions obscured controversy. BMJ, 360:k1287 doi: 10.1136/bmj.k1287Keyword
European Medicines AgencyHES controversy
Drug Evaluation
Hydroxyethyl Starch Derivatives
Safety-Based Drug Withdrawals